Latest News about BMY
Recent news which mentions BMY
Say Hello to 2022’s Dogs of the Dow: 10 Dividend Stocks to Watch
January 27, 2022
From InvestorPlace
2 Dirt-Cheap Dividend Stocks to Buy and Hold Forever
January 27, 2022
From Motley Fool
Hoth's Management Team And Scientific Advisory Board Report Wrapping Up A Busy 2021 Of Clinical Research
January 27, 2022
From Benzinga
The Daily Biotech Pulse: Gilead's Blood Cancer Studies Placed On Partial Clinical Hold, Immunocore Gets FDA Nod, NRx Touts Positive COVID-19 Data
January 26, 2022
From Benzinga
5 Buffett Stocks to Buy Hand Over Fist in 2022
January 24, 2022
From Motley Fool
What's the Outlook for Illumina?
January 23, 2022
From Motley Fool
What's Behind Bristol Myers Squibb's Latest Partnership?
January 22, 2022
From Motley Fool
4 Perfect Dividend Stocks to Buy if There's a Stock Market Crash
January 20, 2022
From Motley Fool
3 Healthcare Stocks Ignoring the Market Mayhem
January 19, 2022
From InvestorPlace
2 Best Warren Buffett Dividend Stocks to Buy Now
January 19, 2022
From Motley Fool
Looking Into Bristol-myers Squibb Company's Recent Short Interest
January 14, 2022
Tickers
BMY
From Benzinga
3 Biotech Stocks Wall Street Thinks Could Soar 50% or More in 2022
January 14, 2022
From Motley Fool
4 Biotech Acquisitions We'd Like to See in 2022
January 14, 2022
From Motley Fool
This Company Believes Physics, Not Chemistry, Is the Best Way To Develop Successful Protein Therapeutics
January 13, 2022
From Benzinga
The Daily Biotech Pulse: Adagio's Antibody Effective Against Omicron, Sarepta Terminates Gene Therapy Deal, AstraZeneca Inks Oncology Pact
January 13, 2022
From Benzinga
Bristol Myers, 2seventy Pull Plug On Multiple Myeloma CAR-T As Abecma Sales Gain Momentum
January 11, 2022
From Benzinga
From Benzinga
3 Top Stock Trades for the Week of Jan. 10, 2022
January 10, 2022
From InvestorPlace
Bristol Myers Squibb Shares Jump After J.P. Morgan Healthcare Conference Presentation
January 10, 2022
Tickers
BMY
From Benzinga
Bristol Myers, Century Therapeutics Ink Pact For iPSC-Derived Allogeneic Cell Therapies
January 10, 2022
From Benzinga
3 Big FDA Approvals to Watch For in Q1 2022
January 09, 2022
From Motley Fool
From Motley Fool
This ‘cash cow’ value-stock strategy can fatten your portfolio even if you fear the Fed
January 06, 2022
From MarketWatch
7 Pharmaceutical Stocks That Could Make You Rich
January 06, 2022
From InvestorPlace
From Motley Fool
23 dividend stocks that can pass this strict quality screen
January 04, 2022
From MarketWatch
This Big Pharma Stock Is Enriching Shareholders With Its Dividend. But Is It a Buy?
January 04, 2022
From Motley Fool
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.